Musich Shirley, Wang Shaohung S, Slindee Luke B, Saphire Lynn, Wicker Ellen
Research for Aging Populations, Optum, 315 E. Eisenhower Parkway, Suite 305, Ann Arbor, MI, 48108, USA.
Informatics and Data Science, Optum, 12700 Whitewater Drive, Minnetonka, MN, 55343, USA.
Drugs Aging. 2018 May;35(5):467-476. doi: 10.1007/s40266-018-0543-5.
Prescription sleep medications are often utilized to manage sleep problems among older adults even though these drugs are associated with multiple risks.
The aim was to determine the prevalence and characteristics of new-onset compared to chronic sleep medication users and to examine factors associated with the conversion from new to chronic use. A secondary objective was to investigate the impact of sleep medications on health outcomes of injurious falls and patterns of healthcare utilization and expenditures.
A 25% random sample of adults ≥ 65 years with 3-year continuous AARP Medicare Supplement medical and AARP MedicareRx drug plan enrollment was utilized to identify new-onset and chronic sleep medication users. Prescription sleep medication drugs were defined using National Drug Codes (NDCs); falls or hip fractures were identified from diagnosis codes. New users had no sleep medication use in 2014, but initiated medication use in 2015; chronic users had at least one sleep medication prescription in 2014 and in 2015; both groups had follow-up through 2016. Characteristics associated with new users, new users who converted to chronic use, and chronic users were determined using multivariate logistic regression. Prevalence of falls, healthcare utilization and expenditures were regression adjusted.
Among eligible insureds, 3 and 9% were identified as new-onset and chronic sleep medication users, respectively. New-onset sleep medication prescriptions were often associated with an inpatient hospitalization. The strongest characteristics associated with new users, those who converted to chronic use, and chronic users were sleep disorders, depression and opioid use. About 50% of new users had > 30 days' supply; 25% converted to chronic use with ≥ 90 days' supply. The prevalence of falls for new-onset users increased by 70% compared to a 22% increase among chronic users.
New-onset and chronic sleep medication users were characterized by sleep disorders, depression and pain. Addressing the underlying problems associated with sleep problems among older adults may decrease the need for sleep medications and thus reduce the risk of sleep medication-related adverse events.
尽管处方睡眠药物存在多种风险,但老年人睡眠问题的管理中仍经常使用这些药物。
确定新开始使用与长期使用睡眠药物的人群的患病率及特征,并研究从新开始使用转变为长期使用的相关因素。次要目的是调查睡眠药物对跌倒致伤的健康结局以及医疗保健利用模式和支出的影响。
采用年龄≥65岁、连续3年参加美国退休人员协会(AARP)医疗保险补充计划及AARP医疗保险药品计划的成年人的25%随机样本,以确定新开始使用和长期使用睡眠药物的人群。使用国家药品代码(NDC)定义处方睡眠药物;通过诊断代码识别跌倒或髋部骨折。新使用者在2014年未使用睡眠药物,但在2015年开始用药;长期使用者在2014年和2015年至少有一张睡眠药物处方;两组均随访至2016年。使用多因素逻辑回归确定与新使用者、转变为长期使用的新使用者和长期使用者相关的特征。对跌倒的患病率、医疗保健利用和支出进行回归调整。
在符合条件的参保者中,分别有3%和9%被确定为新开始使用和长期使用睡眠药物的人群。新开始使用睡眠药物的处方通常与住院治疗有关。与新使用者、转变为长期使用的人群和长期使用者相关的最显著特征是睡眠障碍、抑郁症和阿片类药物使用。约50%的新使用者有超过30天的供应量;25%转变为长期使用且供应量≥90天。新开始使用睡眠药物人群的跌倒患病率增加了70%,而长期使用者增加了22%。
新开始使用和长期使用睡眠药物的人群的特征为睡眠障碍、抑郁症和疼痛。解决老年人睡眠问题相关的潜在问题可能会减少对睡眠药物的需求,从而降低与睡眠药物相关的不良事件风险。